Home / Tag Archives: triple agonists diabetes

Tag Archives: triple agonists diabetes

The Glucagon Paradox: Why Activating a “Blood Sugar Hormone” Can Improve Metabolic Health

Medical illustration showing GLP-1, GIP, and glucagon receptors working together to improve metabolism, weight loss, liver health, and blood glucose control in triple agonist diabetes therapy.

For decades, glucagon has been viewed as insulin’s opposite. While insulin lowers blood glucose, glucagon raises it by signaling the liver to release stored sugar into the bloodstream. Because of this, glucagon has traditionally been considered a hormone to suppress in people living with type 2 diabetes. However, modern research …

Read More »